Pain Response to Open Label Placebo in Induced Acute Pain in Healthy Adult Males
暂无分享,去创建一个
[1] R. Gabriel,et al. State of the art opioid-sparing strategies for post-operative pain in adult surgical patients , 2019, Expert opinion on pharmacotherapy.
[2] M. Schaefer,et al. Why do open-label placebos work? A randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis , 2018, PloS one.
[3] I. Kirsch,et al. Is the rationale more important than deception? A randomized controlled trial of open-label placebo analgesia , 2017, Pain.
[4] H. Flor,et al. Placebo effects of a sham opioid solution: a randomized controlled study in patients with chronic low back pain , 2017, Pain.
[5] P. Donnan,et al. Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis , 2017, BMC Nephrology.
[6] S. M. Vambheim,et al. A systematic review of sex differences in the placebo and the nocebo effect , 2017, Journal of pain research.
[7] N. Roberts,et al. Effects of placebos without deception compared with no treatment: A systematic review and meta‐analysis , 2017, Journal of evidence-based medicine.
[8] L. Colloca,et al. Nocebo and pain: an overview of the psychoneurobiological mechanisms , 2017, Pain reports.
[9] J. Bruhn,et al. Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti‐Inflammatory Drugs , 2017, Pain practice : the official journal of World Institute of Pain.
[10] Christoph Werner,et al. Trust in the health care professional and health outcome: A meta-analysis , 2017, PloS one.
[11] I. Kirsch,et al. Open-label placebo treatment in chronic low back pain: a randomized controlled trial , 2016, Pain.
[12] J. Gurwitz,et al. Safety of metamizole: a systematic review of the literature , 2016, Journal of clinical pharmacy and therapeutics.
[13] P. Enck,et al. Relieving pain using dose-extending placebos: a scoping review. , 2016, Pain.
[14] T. Kaptchuk,et al. Are Open‐Label Placebos Ethical? Informed Consent and Ethical Equivocations , 2016, Bioethics.
[15] J. Micó,et al. A review of chronic pain impact on patients, their social environment and the health care system , 2016, Journal of pain research.
[16] M. Jensen,et al. Meta-analysis of placebo responses in central neuropathic pain: impact of subject, study, and pain characteristics , 2016, Pain.
[17] K. Rentsch,et al. Does Fentanyl Lead to Opioid-induced Hyperalgesia in Healthy Volunteers?: A Double-blind, Randomized, Crossover Trial , 2016, Anesthesiology.
[18] T. Kaptchuk,et al. Placebo Effects in Medicine. , 2015, The New England journal of medicine.
[19] Peter Kreiner,et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. , 2015, Annual review of public health.
[20] F. Benedetti. Placebo Effects: From the Neurobiological Paradigm to Translational Implications , 2014, Neuron.
[21] E. Pogatzki-Zahn,et al. Nonopioid analgesics for postoperative pain management , 2014, Current opinion in anaesthesiology.
[22] H. Flor,et al. Placebo analgesia: Clinical applications , 2014, PAIN®.
[23] D. Hoaglin,et al. Altered Placebo and Drug Labeling Changes the Outcome of Episodic Migraine Attacks , 2014, Science Translational Medicine.
[24] C. Hornuss,et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting. , 2012, British journal of anaesthesia.
[25] M. Allard,et al. Who Is at Risk for Postdischarge Nausea and Vomiting after Ambulatory Surgery? , 2012, Anesthesiology.
[26] Lee S. Simon. RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH , 2012, Military medicine.
[27] F. Benedetti,et al. Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors , 2011, Nature Medicine.
[28] C. Woolf. Central sensitization: Implications for the diagnosis and treatment of pain , 2011, PAIN.
[29] I. Kirsch,et al. Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome , 2010, PloS one.
[30] Alban Latremoliere,et al. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. , 2009, The journal of pain : official journal of the American Pain Society.
[31] D. Drossman,et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome , 2008, BMJ : British Medical Journal.
[32] Fabrizio Benedetti,et al. A comprehensive review of the placebo effect: recent advances and current thought. , 2008, Annual review of psychology.
[33] F. Benedetti,et al. Opioid-Mediated Placebo Responses Boost Pain Endurance and Physical Performance: Is It Doping in Sport Competitions? , 2007, The Journal of Neuroscience.
[34] P. McGettigan,et al. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. , 2006, JAMA.
[35] B. Collett,et al. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment , 2006, European journal of pain.
[36] Pierre Rainville,et al. Direct Comparison of Placebo Effects on Clinical and Experimental Pain , 2006, The Clinical journal of pain.
[37] Luana Colloca,et al. Overt versus covert treatment for pain, anxiety, and Parkinson's disease , 2004, The Lancet Neurology.
[38] S. Dickerson,et al. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. , 2004, Psychological bulletin.
[39] Jürgen Schüttler,et al. A New Model of Electrically Evoked Pain and Hyperalgesia in Human Skin: The Effects of Intravenous Alfentanil, S (+)-ketamine, and Lidocaine , 2001, Anesthesiology.
[40] J. Tijssen,et al. Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos , 2000, Journal of Neurology.
[41] F. Benedetti,et al. Neuropharmacological Dissection of Placebo Analgesia: Expectation-Activated Opioid Systems versus Conditioning-Activated Specific Subsystems , 1999, The Journal of Neuroscience.
[42] C. Kirschbaum,et al. Salivary cortisol in psychoneuroendocrine research: Recent developments and applications , 1994, Psychoneuroendocrinology.
[43] P. Sandroni,et al. International association for the study of pain , 1986, Pain.
[44] H. Fields,et al. MECHANISM OF PLACEBO ANALGESIA , 1978, The Lancet.
[45] H. Fields,et al. THE MECHANISM OF PLACEBO ANALGESIA , 1978, The Lancet.
[46] C. Welch,et al. REDUCTION OF POSTOPERATIVE PAIN BY ENCOURAGEMENT AND INSTRUCTION OF PATIENTS. A STUDY OF DOCTOR-PATIENT RAPPORT. , 1964, The New England journal of medicine.
[47] C. Lindsell,et al. Randomized Controlled Trial , 2020, Encyclopedia of Behavioral Medicine.
[48] C. Woolf,et al. Towards a mechanism-based approach to pain diagnosis , 2016 .
[49] H. Flor,et al. Clinical and ethical implications of placebo effects: enhancing patients' benefits from pain treatment. , 2014, Handbook of experimental pharmacology.
[50] C. King,et al. Salivary cortisol and soluble tumor necrosis factor-α receptor II responses to multiple experimental modalities of acute pain. , 2012, Psychophysiology.
[51] K. Wiech,et al. Supplementary Materials for The Effect of Treatment Expectation on Drug Efficacy: Imaging the Analgesic Benefit of the Opioid Remifentanil , 2011 .
[52] E. Aardal,et al. Cortisol in Saliva - Reference Ranges and Relation to Cortisol in Serum , 1995, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.